1. Expression of vascular endothelial growth factor and its correlation with clinical symptoms and endoscopic findings in patients with chronic radiation proctitis.
- Author
-
Trzcinski, R., Dziki, A., Mik, M., Kujawski, R., Dziki, L., Brys, M., Moszynska‐Zielinska, M., and Chalubinska‐Fendler, J.
- Subjects
- *
VASCULAR endothelial growth factors , *PROCTITIS , *RADIOTHERAPY , *UTERINE cancer , *ENZYME-linked immunosorbent assay , *NEOVASCULARIZATION , *ENDOSCOPIC surgery - Abstract
Abstract: Aim: The aim of this study was to assess the expression of vascular endothelial growth factor (VEGF) as a key proangiogenic factor and determine whether there is any correlation between its expression and clinical symptoms or endoscopic changes in patients with chronic radiation proctitis (ChRP). Method: Fifty patients who had all undergone radiotherapy for prostate, cervical or uterine cancer were included in the study (37 women, 13 men). There was a control group of 20 patients (9 women, 11 men). The Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer (RTOG/EORTC) scoring system was used for grading the severity of the proctitis. Endoscopic scoring of late rectal mucosal damage was performed using Gilinsky's classification. Serum levels of VEGF were analysed by the enzyme‐linked immunosorbent assay method. Results: Most patients presented with Grade 1 symptoms. Endoscopic assessment showed that most patients had Grade 1 late rectal mucosal damage. The predominant endoscopic finding was the presence of telangiectasia. Assessment of VEGF correlation between the control group and the degrees of endoscopic changes showed statistically significant differences for all three degrees (
P <P =P =P =P =- Published
- 2018
- Full Text
- View/download PDF